These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23124151)

  • 21. A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.
    Takeuchi N; Arai T; Kitaichi M; Inoue Y
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24072826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute.
    Kawabata H; Kadowaki N; Nishikori M; Kitawaki T; Kondo T; Ishikawa T; Yoshifuji H; Yamakawa N; Imura Y; Mimori T; Matsumura Y; Miyachi Y; Matsubara T; Yanagita M; Haga H; Takaori-Kondo A
    J Clin Exp Hematop; 2013; 53(1):69-77. PubMed ID: 23801137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of multicentric Castleman's disease associated with dystrophic epidermolysis bullosa using anti-interleukin-6 receptor antibody.
    Naruse S; Takashima S; Fujita Y; Kataoka H; Kawamura N; Natsuga K; Ujiie H
    J Dermatol; 2024 Aug; 51(8):e268-e269. PubMed ID: 38482904
    [No Abstract]   [Full Text] [Related]  

  • 24. Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels.
    Newsom-Davis T; Bower M; Wildfire A; Thirlwell C; Nelson M; Gazzard B; Stebbing J
    Leuk Lymphoma; 2004 Sep; 45(9):1939-41. PubMed ID: 15223659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
    Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse cryptococcal pneumonia in multicentric Castleman's disease with elevated serum IgG
    Takiguchi J; Tomioka H; Kamei K; Kawabata Y
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36944440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman's Disease: a case report.
    Anderson S; Sasson SC; Lee FJ; Cooper W; Larsen S; Garsia R
    BMC Infect Dis; 2016 Feb; 16():53. PubMed ID: 26831502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
    Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
    Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
    Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
    Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman's disease.
    Arita Y; Sakata Y; Sudo T; Maeda T; Matsuoka K; Tamai K; Higuchi K; Shioyama W; Nakaoka Y; Kanakura Y; Yamauchi-Takihara K
    Heart Vessels; 2010 Sep; 25(5):444-7. PubMed ID: 20676969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy.
    Awano N; Inomata M; Sonoda Y; Kondoh K; Ono R; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
    J Clin Exp Hematop; 2013; 53(1):101-5. PubMed ID: 23801141
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous castleman's disease responds to anti interleukin-6 treatment.
    Ahmed B; Tschen JA; Cohen PR; Zaki MH; Rady PL; Tyring SK; Corringham RE; Kurzrock R
    Mol Cancer Ther; 2007 Sep; 6(9):2386-90. PubMed ID: 17766835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.
    Cervera Grau JM; Galiana Esquerdo G; Llorca Ferrándiz C; Briceño García H; Díaz Castellano M; Férriz Moreno P
    Clin Transl Oncol; 2006 Jul; 8(7):540-1. PubMed ID: 16870545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentric Castleman's disease in a Ghanaian adult.
    Dei-Adomakoh YA; Segbefia C; Ekem I; Taylor A
    Ghana Med J; 2013 Jun; 47(2):92-5. PubMed ID: 23966747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of multicentric Castleman's disease having lung lesion successfully treated with humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Higuchi T; Nakanishi T; Takada K; Matsumoto M; Okada M; Horikoshi H; Suzuki K
    J Korean Med Sci; 2010 Sep; 25(9):1364-7. PubMed ID: 20808682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of cardiomyopathy with tocilizumab in a case of HIV-negative Castleman's disease.
    Man L; Goudar RK
    Eur J Haematol; 2013 Sep; 91(3):273-276. PubMed ID: 23786462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenectomy induced complete remission in a patient with multicentric Castleman's disease and autoimmune hemolytic anemia.
    Lerza R; Castello G; Truini M; Ballarino P; Tredici S; Cavallini D; Pannacciulli I
    Ann Hematol; 1999 Apr; 78(4):193-6. PubMed ID: 10348152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
    Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
    AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases.
    Nagao A; Nakazawa S; Hanabusa H
    J Hematol Oncol; 2014 Jan; 7():10. PubMed ID: 24438824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.
    Song SN; Tomosugi N; Kawabata H; Ishikawa T; Nishikawa T; Yoshizaki K
    Blood; 2010 Nov; 116(18):3627-34. PubMed ID: 20644113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.